CompletedNo phase
Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-dependent Hypercortisolism
Key facts
- Who runs it
- Peking University First Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 121 people enrolled
- Started
- 1 Aug 2017
- Ended
- 1 Apr 2025
- Type of study
- Observational
- Treatments tested
- observational diagnostic model development
- Record updated
- 15 December 2025
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- In all, 111 patients (meadian age: 54years; 64.9% female) were included and received postoperative steroid replacement therapy, among whom 65 were diagnosed with subclinical Cushing's syndrome (SCS) and 46 with overt Cushing's syndrome (CS)
Who cannot take part
- none
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To identify preoperative factors influencing the duration of steroid replacement therapy after adrenalectomy/adrenal-sparing surgery in patients with non-ACTH-dependent hypercortisolism.
Treatments tested
- observational diagnostic model development
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 15 December 2025